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Abstract
Thyroid autoimmune reactions start with an accumulation
of mainly dendritic cells in the thyroid. There is increas-
ing evidence that, apart from being antigen-presenting
cells, they are also able to control the growth and
hormone synthesis of neighbouring endocrine cells. The
questions thus arise: are dendritic cells accumulating in
the pre-autoimmune thyroid in response to an altered
proliferative or metabolic activity of thyrocytes, and do
cytokines, monocyte chemoattractants, or both, have a role
in their accumulation? We have investigated these ques-
tions in thyrocytes of the biobreeding diabetes-prone
(BB-DP) rat in relation to the start of the intrathyroid
accumulation of dendritic cells – that is, at about 9 weeks
of age.
BB-DP rats and Wistar rats (controls) were studied
from 3 to 20 weeks of age. Hyperplastic goitre develop-
ment was studied by assessing the thyroid weight and by
measuring the number of thyrocyte nuclei per 0·01 mm2
thyroid section. In addition, the in situ expression of
interleukin-6 (IL-6), tumour necrosis factor-Æ (TNF-Æ),
monocyte-chemotactic protein-1 (MCP-1), and inter-
cellular adhesion molecule-1 (ICAM-1) were studied
by immunohistochemistry. The in vitro proliferative ca-
pacity of BB-DP and Wistar thyrocytes was measured
by tritiated-thymidine ([3H]TdR) and bromodeoxy-
uridine (BrdU) incorporation into reconstituted, TSH-
and non-TSH-stimulated, cultured thyroid follicles.
Further in vitro studies consisted of measurement of
the production of thyroxine (T4), triiodothyronine (T3),
thyroglobulin, IL-6, TNF-Æ and MCP-1 by the thyroid
follicles.
BB-DP rats developed a small hyperplastic goitre
between the ages of 9 and 12 weeks. The in vitro
proliferative rate of thyrocytes isolated from hyperplastic
BB-DP thyroids was significantly lower than that of
Wistar thyrocytes. This phenomenon also occurred in
follicles isolated from BB-DP rats before hyperplastic
goitre development, which produced significantly less
T4, but more T3, than did Wistar follicles of the same
age. At the time of and after hyperplastic goitre
development, BB-DP follicles exhibited altered meta-
bolic behaviour and produced significantly more T4, but
equal amounts of T3 compared with both Wistar follicles
of the same age and follicles of younger BB-DP rats
(both under basal conditions and TSH-stimulated).
In vitro IL-6 production by these BB-DP thyroid follicles
was also increased. There was no noteworthy diVerence
in production of thyroglobulin and MCP-1 between
BB-DP and Wistar follicles at any age. TNF-Æ was not
produced by BB-DP or Wistar thyroid follicles.
Immunohistochemistry revealed the expression of IL-6
by both BB-DP and Wistar thyroid follicle cells at all
times of sampling. MCP-1 and TNF-Æ were expressed
only when infiltrates were present in BB-DP thyroids
(restricted to leucocytes, ages >18 weeks). Modest
ICAM-1 expression was restricted to large blood vessels
in both BB-DP and Wistar thyroids; in the case of
infiltrates (BB-DP rat) alone, high ICAM-1 expression
was found on blood vessels and leucocytes in these
infiltrations.
At the time of intrathyroidal dendritic cells accumu-
lation, BB-DP rats develop a small hyperplastic goitre. At
that time there is also in vitro evidence for a shift to a
higher production of thyroxine and IL-6 from thyrocyte
follicles. The in vitro proliferation rate of BB-DP thyrocytes
is, however, abnormally low (both in the pre- and
hyperplastic period). Similar pre-autoimmune thyroid
growth abnormalities have been described in another
animal model of thyroid autoimmune disease, the obese
strain chicken.
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Introduction
The animal models of spontaneously developing auto-
immune thyroid disease (AITD) are the biobreeding
diabetes-prone (BB-DP) rat, the non-obese diabetic
(NOD) mouse and the obese strain (OS) chicken. The first
immunological sign of AITD in these three animal models
is an accumulation of antigen-presenting cells (APCs),
mainly dendritic cells, in the thyroid (Voorbij et al. 1990,
Many et al. 1995, Hala et al. 1996). This accumulation of
APCs precedes the triggering of autoreactive T and B
lymphocytes in the thyroid-draining lymph nodes and the
subsequent influx of T and B lymphocytes into the thyroid
(focal thyroiditis; Voorbij et al. 1990, Many et al. 1995).
High numbers of APCs can also be detected in human
forms of AITD, Hashimoto’s and Graves’ goitres (Kabel
et al. 1988). In Graves’ goitres, dendritic cells often
accumulate in the absence of a noteworthy lymphocytic
infiltration (Kabel et al. 1988). The question thus arises:
‘Why do dendritic cells start to accumulate in thyroid
glands that later become the target of an autoimmune
attack?’
For a further exploration of this question it is important
to note that endocrine tissues normally contain dendritic
cells and macrophages. Although dendritic cells are
present in low numbers in the normal thyroid (Kabel et al.
1988, Mooij et al. 1993a), networks of relatively large
numbers can be found in the anterior pituitary (Allaerts
et al. 1996, 1997) and in the gonads (Bra¨nnstro¨m &
Norman 1993, Hoek et al. 1996). In the anterior pituitary,
dendritic cells form a subgroup of the network of
folliculo-stellate cells (Allaerts et al. 1996). Apart from
being excellent accessory cells in T cell stimulation, these
dendritic cells are also capable of regulating the hormonal
responses of neighbouring endocrine cells (Allaerts et al.
1994, 1996, 1997). The cytokine, interleukin-6 (IL-6),
is believed to have an important role in this regulation
(Allaerts et al. 1994, 1997). With regard to the presence
of dendritic cells and macrophages in the ovary and
testis, these classical APCs have a role not only in the
regulation of ovulation (Bra¨nnstro¨m & Norman 1993),
but also in the growth and steroid production of granulosa,
theca, luteal and Leydig cells (Gaytan et al. 1995, Hoek
et al. 1996, Katabuchi et al. 1996). Recently, we have
obtained preliminary evidence that dendritic cells are also
involved in the regulation of the growth of thyrocytes:
Wistar rat splenic dendritic cells – which are excellent
APCs – were capable of downregulating the uptake of
tritiated thymidine ([3H]TdR) and bromodeoxyuridine
(BrdU) of Wistar rat thyrocytes kept in follicle culture
(manuscript in preparation). Interestingly, dendritic cells
accumulate in the thyroid during goitrous conditions,
for example in simple human goitres (Kabel et al. 1988)
and in iodine-deficient goitres both in humans
(Wilders-Truschnig et al. 1989) and in the Wistar rat
(Mooij et al. 1993a).
This accumulating evidence that dendritic cells have a
role in the regulation of growth and hormone production
of endocrine cells (Bra¨nnstro¨m & Norman 1993, Allaerts
et al. 1994, 1996, 1997, Gaytan et al. 1995, Hoek et al.
1996, Katabuchi et al. 1996), is highly suggestive that the
accumulation of dendritic cells in thyroid glands, which
later become the targets of an autoimmune reaction,
may be a consequence of an abnormal proliferative rate
or metabolic activity of pre-autoimmune thyrocytes.
Interestingly, many papers have, indeed, reported pre-
autoimmune abnormalities in the growth and function of
thyrocytes of the OS chicken (reviewed by Sundick 1989).
In this study, we have investigated whether there are
pre-autoimmune abnormalities in the proliferative rate and
in the metabolic activity of BB-DP thyrocytes compared
with Wistar thyrocytes. We studied hyperplastic goitre
development (thyroid weight increase and the number of
thyrocyte nuclei per area of histological thyroid section),
uptake of [3H]TdR in isolated and in vitro reconstituted
thyroid follicles (verified by BrdU labelling), and the
production of thyroxine (T4), tri-iodothyronine (T3), and
thyroglobulin by isolated and in vitro reconstituted thyroid
follicles.
Adhesion molecules on thyroid endothelial cells and
locally produced cytokines/monocyte-chemokines in
pre-autoimmune stages are probably instrumental in the
enhanced attraction of dendritic cells (for which mono-
cytes are among the important precursors, Mooij et al.
1994, Peters et al. 1996) into the BB-DP thyroid. Because
of limited availability of antibodies, from all the various
cytokines and growth factors involved in monocyte
extravasation and the transition of monocytes to dendritic
cells, we were able to study only intercellular adhesion
molecule-1 (ICAM-1), monocyte chemotactic protein-1
(MCP-1), IL-6 and tumour necrosis factor-Æ (TNF-Æ).
ICAM-1 is one of the important endothelial adhesion
molecules, MCP-1 is an important monocyte chemo-
attractant, and IL-6 and TNF-Æ are, alongside granulocyte
monocyte colony stimulating factor (GM-CSF) and
IL-4, important cytokines for monocyte to dendritic cell
transition (Peters et al. 1996). The IL-6, TNF-Æ and
MCP-1 production by BB-DP thyrocytes, and the
ICAM-1 expression in the BB-DP thyroid were studied
in situ (immunohistochemistry) as well as in vitro (thyroid
follicle cultures).
Data were analysed taking into account the time at
which intrathyroid accumulation of dendritic cells begins
in the BB-DP rat, which is at about 9 weeks of age
(Voorbij et al. 1990, Mooij et al. 1993b).
Materials and Methods
Animals
BB-DP rats were bred for more than 20 generations in the
Experimental Animal Centre of the Erasmus University
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Rotterdam, The Netherlands. The strain originates from
the BB/WOR strain via the BB/Organon strain. All
rats were kept under controlled conditions of light
(12 h light : 12 h darkness cycle) during the experiments.
Between 12 and 20 weeks of age, 90% of our BB-DP rats
develop Æ-colloid antibodies detectable in serum, and
during the same period 70–80% of our rats become
diabetic (glucosuria). Normal pellets (Am-II, Hope Farms
BV, Woerden, The Netherlands; 0·35 mg iodine/kg) and
tap water were available to all rats ad libitum. Control
Wistar rats were purchased from Harlan, Zeist, The
Netherlands.
Histology of the thyroid, quantification of histomorphological
thyroid parameters and detection of cytokines in situ
BB-DP and Wistar rats were asphyxiated with carbon
dioxide. Thyroid glands were excised, weighed and there-
after either immediately fixed overnight in a 10% (v/v)
formalin solution (for haematoxylin–eosin staining) or
embedded in OCT (Tissue-Tek, Miles, Elkhart, IN,
USA), snap-frozen in liquid nitrogen and stored at
"70 )C until required for immunohistochemistry.
The formalin-fixed tissues were processed routinely and
embedded in paraYn. Serial sections (6 µm) of blocks
containing six separate thyroids were cut and routinely
stained with haematoxylin–eosin. These sections were
used to measure the thyrocyte nuclear areas and the
number of thyrocyte nuclei per unit surface section area.
For this purpose, a microscope (Axioscope, Zeiss, Weesp,
The Netherlands) connected to a VIDAS-RT image-
analysis system (Kontron Elektronik GmbH/Zeiss) was
used; magnifications were#400 and#200 respectively.
Immunostaining for cytokines was performed as
described earlier (Eertwegh van den et al. 1991) with
minor modifications. In short, cryostat sections (8 µm)
were cut, mounted on glass slides and kept overnight
under high humidity at room temperature. Tissue sections
were fixed for 10 min in acetone containing 0·02% (v/v)
H2O2 (Merck, Munich, Germany) to block endogenous
peroxidase activity. Slides were dried and incubated with
the primary antibody diluted in PBS (Merck) contain-
ing 0·2% (v/v) BSA (Organon Technika, Eppelheim,
Germany) for 1 h at room temperature. The following
polyclonal rabbit antibodies were used: anti-human IL-6
(1 : 10; Genzyme, Diagnostics, Cambridge, UK), anti-
mouse TNF-Æ (1 : 10; Genzyme) and anti-mouse MCP-1
(1 : 50; a kind gift from Dr R M Strieter; Paine et al.
1993). These antibodies crossreact with rat cytokines
(Diamond & Pesek 1991, Paine et al. 1993). For the
detection of MCP-1, mouse anti-rat MCP-1 was also used
(undiluted culture supernatant; a kind gift from Dr K
Takahashi; Sakanashi et al. 1994). Immunostaining with
anti-rat ICAM-1 (1:10; Cedarlane, Hornby, Ontario,
Canada) was performed omitting the overnight step under
high humidity. After incubation, slides were rinsed three
times with PBS–0·2% BSA and subsequently further
incubated with peroxidase-conjugated secondary anti-
bodies (in PBS containing 1% normal rat serum) and
developed as described by Eertwegh van den et al. (1991).
Isolation and in vitro culture of thyroid follicles
Thyroid follicles were isolated according to slightly
modified methods described in detail elsewhere (Denef
et al. 1980, Spinel-Comez et al. 1990). The isolated follicles
were resuspended under adherent conditions and cultured
in 5–10 ml Ham’s F12 medium (Gibco, BRL-Life Tech-
nologies, Breda, The Netherlands), supplemented with a
five-hormone mixture (Ambesi-Impiombato et al. 1980)
and 1% fetal calf serum (FCS). The viability of the isolated
follicles was routinely assessed by the trypan blue exclusion
test.
After reconstitution for 24 h, the follicles were further
cultured (37 )C, 5% CO2, water-saturated atmosphere) in
24-well plates (Costar Europe Ltd, Badhoevedorp, The
Netherlands) in the presence of 0·1 µM KI (Merck) with
or without various concentrations of bovine (b) thyroid-
stimulating hormone (TSH; Sigma Chemical Co.,
Axel, The Netherlands) or recombinant human (rh) TSH
(Sigma; see Results). After 24 h the culture supernatants
were aspirated, centrifuged at 500 g for 5 min and stored
at "20 )C until required for thyroid hormone, thyro-
globulin or cytokine determinations.
The measurement of in vitro thyroid hormone, thyroglobulin
and cytokine production
The T4 and T3 contents of the supernatants
were measured by conventional radioimmunoassays
(Dr T J Visser, Dr R Docter, Mr H van Toor, Department
of Internal Medicine, University Hospital Dijkzigt,
Rotterdam, The Netherlands). T3 and T4 standards were
diluted in Ham’s F12 culture fluid plus supplements. Each
individual supernatant sample was assayed in duplicate.
Determination of the thyroglobulin concentrations in
the follicle supernatants was performed using a newly
developed sandwich ELISA. Microtitre plates (Falcon,
Becton Dickinson Labware, New Jersey, USA) were
coated overnight at 4 )C with a specific polyclonal anti-
serum against rat thyroglobulin in PBS (4·0 µg protein A
purified immunoglobulins per well). Non-specific binding
was prevented by preincubating the plates with PBS–0·5%
BSA–0·05% (v/v) Tween 20 (Merck) for 1 h. Rat thyro-
globulin (31–2000 ng/ml), which was used as a standard,
and the culture supernatants were then diluted in Ham’s
F12 medium (plus supplements) and incubated for 1·5 h.
Finally, the plates were incubated during 1·5 h with a
mixture of two monoclonal (mouse) antibodies against
rat thyroglobulin (1 : 2000 in PBS; clones 2F2 and
2H11), followed by incubation for 1 h with a polyclonal
anti-mouse serum conjugated with peroxidase (1 : 1000
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in PBS; DAKO, Glostrup, Denmark). Bound enzyme
activity was measured with 0·05 M KNaPO4 (Merck)
buVer (pH 5·6) containing 6 mg/ml ortho-phenyldiamine
dihydrochloride (Sigma) and 0·015% H2O2 (Merck) as
substrate. This reaction was stopped with 2 M HCl
(Merck) and the optical density was read at 492 nm. All
incubation steps were performed at room temperature and
between these steps the wells were washed at least three
times with 0·9% (w/v) NaCl (Merck)–0·1% Tween 20 in
aqua dest. Rat thyroglobulin and antibodies against this
thyroglobulin were developed and kindly provided by Dr
J J M de Vijlder, Academic Medical Centre, Department
of Pediatrics, Amsterdam, The Netherlands.
IL-6 was detected in the B9 bioassay developed by
Aarden et al. (1987). The murine fibroblast cell line,
WEHI 164·13, was used to assay TNF bioactivity accord-
ing to Espevik & Nissen-Meyer (1986). Both techniques
have been described in detail before. Thyroid follicle
culture supernatants were serially diluted and assayed in
triplicate.
Rat MCP-1 in the culture supernatants of the follicles
was determined with a commercial available ELISA kit
(Immunosource, Zoersal-Halle, Belgium) according to
techniques advised by the manufacturer.
The measurement of in vitro thyrocyte proliferation
Thyroid follicles were labelled with [3H]TdR during the
last 5 h of culture. In brief, the follicles were washed and
put on fresh Ham’s F12 medium (plus supplements
and diVerent concentrations of bTSH) in 96-well plates
(Costar). Subsequently, 1 µCi/well methyl-[3H]TdR
(Amersham International, Amersham, England) was
added. After the period of labelling at 37 )C in a 5% CO2
water-saturated incubator, the follicles were harvested on
filter paper and radioactivity was counted in a liquid
scintillation analyser (LKB Betaplate; Wallac, Turku,
Finland). In some experiments, follicles (obtained
from both rat strains) were co-cultured with 5 µg/ml
aphidicolin (an inhibitor of DNA polymerase; Sigma;
Okugawa et al. 1995) or exposed to 2000 rad X-
irradiation. These treatments were applied to prevent
replication of DNA, and thus to ensure that radioactivity
measured in the samples that did not undergo these
treatments reflected the S-phase of the cell cycle (Maurer
1981). Each individual experiment was performed in
duplicate.
To validate further the [3H]TdR incorporation assay,
data were also confirmed with BrdU labelling. For that
purpose, the follicles were incubated at 37 )C in a 5% CO2
water-saturated incubator in the presence of 10 µM BrdU
(BrdU-kit I; Boehringer) during the last 5 h of culture.
Thereafter, the samples were thoroughly washed in
PBS, cytocentrifuged onto glass slides, air-dried and
fixed in pre-cooled 70% (v/v) ethanol (Merck) for 30 min
at "20 )C. The BrdU incorporation was visualized
immunocytochemically according to the instructions of
the manufacturer. The percentage of BrdU-positive
(BrdU+) follicles was evaluated by counting at least 500
follicles per sample. For negative controls, the primary
incubation step was buVer solution without anti-BrdU
antibody.
Statistical analysis
The results are presented as means&s.d. or s.e.m. (see
Figures). Statistical analyses of the quantitative histo-
morphological measurements were performed using the
Student’s t-test (unpaired, two-tailed, InStat computer
program). Statistical analyses of the production of
hormones, thyroglobulin and cytokines and the prolifer-
ative rate of the in vitro cultured thyroid follicles were
performed using Wilcoxon’s rank sum test (two-tailed,
InStat computer program).
Results
Thyroid weight and number of thyrocyte nuclei per surface area
of a thyroid section
Figure 1a shows that, between the ages of 9–12 weeks, the
thyroid weight of BB-DP rats became statistically greater
than that of Wistar rats, and that the BB-DP rat thyroid
continued to grow during our experimental period of
20 weeks, whereas the Wistar thyroid weight had reached
a plateau from 9 weeks of age. From the age of 10 weeks
onwards, morphological signs of thyroid hyperplasia in the
BB-DP rat thyroid were evident: the number of thyrocyte
nuclei per 0·01 mm2 thyroid section surface area was
significantly greater in BB-DP rats than in Wistar rats
(Fig. 1b). Lymphocytic infiltrations were observed in our
BB-DP colony only from the age of 18 weeks, therefore
lymphocytic accumulation did not contribute to goitre
formation in this pre-autoimmune phase.
In vitro thyrocyte proliferation
During the 24 h of culture after the isolation procedure,
fragmented follicles of both BB-DP and Wistar rats
became sphere-like structures again, and contained 30–50
thyrocytes per follicle (judged by inverted microscopy and
haematoxylin–eosin staining). There was no diVerence in
the morphology between BB and Wistar follicles. Because
our culture conditions were low in FCS, the basal–apical
polarity was normal. The reconstituted follicles were
washed and seeded in 24-well plates at a density of 1000
follicles/well. At this stage, 0·1 µM KI and bTSH in
concentrations ranging from 1#10"5 to 5#102 mU/ml
were added to the follicles. Cultures were also performed
in the absence of bTSH.
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During the period of follicle reconstitution, there
was scarcely any spontaneous and inducible uptake
of [3H]TdR (<100 c.p.m.). Preliminary experiments
established a time-dependent eVect of the bTSH-induced
[3H]TdR uptake in thyroid follicles from BB-DP and
Wistar rats after reconstitution time. Maximum bTSH-
induced [3H]TdR uptake was obtained in cultures of 24 h
duration. Exposure to bTSH increased the [3H]TdR
uptake in a dose-dependent manner in thyroid follicles
from both strains, although optimal concentrations diVered
between the two strains (Fig. 2). Figure 2 also shows that
the in vitro proliferative responses of BB-DP and Wistar
follicles diVered: BB-DP rat follicles showed a clearly
lower [3H]TdR uptake than that in Wistar rat follicles.
This lower uptake was found regardless of the times of
sampling: BB-DP thyroid follicles isolated before or during
hyperplastic goitre development both showed a decreased
uptake. In view of the discrepancy between our in vivo and
in vitro data, the specificity of the [3H]TdR uptake with
regard to DNA replication was demonstrated with aphidi-
colin and X-irradiation treatment. Both antiproliferative
treatments reduced >80% (five separate experiments) of
the total [3H]-radioactivity in Wistar and BB-DP follicles
when added to the cultures. This reduction could not be
ascribed to cytotoxity of aphidicolin or X-irradiation: none
of the follicles showed an increased trypan blue uptake or
altered morphology, and furthermore, production of T3
remained unchanged (data not shown).
The data from BrdU labelling were compatible with
those from [3H]TdR uptake. The percentages of BrdU+
follicles (with and without bTSH) were again significantly
greater in Wistar rats than in BB-DP follicles of young rats
(3–8 weeks of age): without bTSH stimulation there were
21&2% and 13&2% positive follicles respectively
(P<0·05; n=6), and after bTSH stimulation there were
43&4% and 27&3% (P<0·01; n=6). There was also
no age-dependency with regard to this diVerence in BrdU
uptake (pre- and hyperplastic periods). During the hyper-
plastic period (9–20 weeks of age), BrdU uptake in Wistar
and BB-DP rats respectively was: non-bTSH stimulated,
26&3% and 16&2% (P<0·05; n=8); bTSH stimulated,
61&4% and 39&3% (P<0·005; n=8). After bTSH
stimulation, Wistar follicles often demonstrated 10–20
BrdU+ nuclei per follicle, whereas BB-DP follicles never
exceeded 5–10 BrdU+ nuclei per follicle.
To study further whether the discrepancy between our
in vivo (goitre) and in vitro (low proliferation) data could be
attributable to a diVerent response of BB-DP and Wistar
thyroid follicles towards other growth factors contaminat-
ing the bTSH preparation, we performed additional
experiments with rhTSH with a purity greater than 99%.
We obtained data similar to those with bTSH, namely a
lower [3H]TdR uptake in BB-DP thyroid follicles than in
Wistar follicles.
Production of thyroid hormones and thyroglobulin by in vitro
cultured rat thyroid follicles
For both the Wistar and the BB-DP follicles, 100 mU/ml
bTSH appeared to be the optimal concentration for the
measurement both of hormone secretion and of cytokine
production. Addition of 6-propyl-2-thiouracil (Sigma;
2 mM) during the culture period inhibited basal and
bTSH-induced hormonal levels in the culture super-
natants (data not shown), indicating that the hormones
assayed in the supernatant were mainly produced by the
cells during the culture period rather than released via
non-specific mechanisms.
Figure 1 Thyroid weight (a), number of nuclei per section area (b,
hyperplasia) and the nuclear areas (c, ‘hypermetabolism’) of BB-DP
rats (/) and Wistar rats (.) at various ages. Means (n§30)&S.D.
are shown. *P<0·05, ***P<0·001 compared with age-matched
Wistar rats (Student’s t-test).
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BB-DP follicles isolated at young age (3–8 weeks of age;
pre-hyperplastic stage) showed a significantly lower basal
T4 secretion compared with age-matched Wistar follicles
(Table 1). The T3 output, however, was significantly
greater in the BB-DP follicles (both basal and bTSH-
stimulated, Table 1), resulting in a relatively high T3/T4
ratio in very young BB-DP rats compared with Wistar
rats. The bTSH-stimulated production of thyroglobulin
from BB-DP follicles was less than that in Wistar follicles
(Table 1).
BB-DP follicles isolated from rats of 9 weeks of age and
older (hyperplastic stage) demonstrated in vitro a clear
increase in T4 production compared with BB-DP follicles
isolated from younger rats (Table 1). This increased
Figure 2 Uptake of [3H]TdR by cultured BB-DP (/) and Wistar (.) rat thyroid follicles (1000/well) in the
absence or presence of various dosages of bTSH. Follicles were isolated from two age groups: 3–8 weeks
and 9–20 weeks of age. Means (n§6)&S.E.M. are shown. *P<0·05, **P<0·01, ***P<0·001 compared with
Wistar (age-matched groups; Wilcoxon’s rank sum test).
Table 1 In vitro production of T3, T4, IL-6 and thyroglobulin (Tg) by BB-DP and Wistar rat thyroid follicles. Values are means&S.E.M.
3–8 weeks of age 9–20 weeks of age
BB-DP rat n Wistar rat n BB-DP rat n Wistar rat n
Unstimulated
T3 (fmol/2000 follicles) 188&15** 10 96&16 10 199&20 27 231&24 14
T4 (fmol/2000 follicles) 890&87* 10 1378&171 10 1518&209* 9 854&113 8
Ratio T3/T4 0·22&0·02*** 10 0·08&0·01 10 0·21&0·05* 9 0·33&0·06 7
Tg (ng/2000 follicles) 2638&229 3 2884&390 5 2935&640 6 3128&352 6
IL-6 (units/2000 follicles) 75&19 8 40&15 4 104&41 3 63&15 6
TSH (100 mU/ml)-stimulated
T3 (fmol/2000 follicles) 268&28* 10 163&26 10 335&35 27 312&31 14
T4 (fmol/2000 follicles) 1262&154 10 1771&239 10 2130&244** 9 968&142 8
Ratio T3/T4 0·22&0·02** 10 0·10&0·02 10 0·26&0·05 9 0·37&0·08 7
Tg (ng/2000 follicles) 2675&62* 3 3708&291 5 3425&626 6 3349&416 6
IL-6 (units/2000 follicles) 232&53 7 154&53 4 477&99* 3 190&35 6
n, Number of experiments. *P<0·05, **P<0·01, ***P<0·001 compared with age group-matched Wistar rats (Wilcoxon’s rank sum test).
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production after 9 weeks of age was also significantly
enhanced (both basal and bTSH-stimulated) compared
with that in Wistar follicles of the same age group.
Production of T3 and thyroglobulin did not diVer between
follicles of BB-DP and Wistar rats.
Morphological signs of hypermetabolism of the thyro-
cytes at the time of in vitro enhanced T4 production were
also evident in the BB-DP hyperplastic goitres. Pathol-
ogists often use the size of the nuclear area of thyrocytes as
a parameter of the metabolic state of the cell, and we also
measured this parameter in thyroid sections (Klencki et al.
1994, Paschke et al. 1995): the nuclear area of thyrocytes
was significantly greater in BB-DP rats of 14 and 20 weeks
of age than in Wistar rats (Fig. 1c).
Production and expression of IL-6, MCP-1, TNF-Æ and
ICAM-1
On cryostat sections, thyrocytes of BB-DP rats in the
period before hyperplastic goitre development (before 9
weeks of age) and of Wistar rats were seen to be stained
with anti-IL-6 antibodies. The immunohistochemical
technique used did not allow a reliable quantification of
this cytokine. No staining was observed with antibodies
against MCP-1 and TNF-Æ. ICAM-1 expression was
modest and restricted to some large venules in sections of
thyroid glands of both the BB-DP and Wistar rat.
In the period during hyperplastic goitre development
(from 9 weeks of age onwards), thyrocytes of BB-DP and
Wistar rats were again positively stained for IL-6. TNF-Æ
and MCP-1 were detected at this time, but only when
infiltrates of lymphoid cells were present in the thyroid
glands of the BB-DP rats (aged 18 weeks and over). In
these cases, cytokine expression was restricted to the areas
of leucocytic infiltration, and in these areas a high expres-
sion of ICAM-1 was also observed on blood vessels and
leucocytes. Thyrocytes were negative.
IL-6 was clearly detectable in the culture supernatants
of rat thyroid follicles. Before 9 weeks of age, there was no
diVerence with regard to IL-6 production between
BB-DP and Wistar thyroid follicles (Table 1). However,
BB-DP follicles isolated after 9 weeks of age pro-
duced significantly more IL-6 than Wistar follicles, when
stimulated with bTSH (Table 1).
Release of MCP-1 was highly variably, ranging from 0
to 580 pg/2000 follicles, and no diVerence was found
between BB-DP rat and Wistar rat thyroid follicles.
Furthermore, MCP-1 release was not upregulated by
bTSH.
TNF-Æ was not produced by BB-DP or Wistar thyroid
follicles at any age.
Discussion
Our data show that BB-DP rats develop a small goitre with
histomorphological signs of hyperplasia and hyperfunction
between the age of 9–12 weeks. Our in vitro findings of a
lower proliferation rate of ‘hyperplastic’ BB-DP thyrocytes
kept in follicle culture, compared with that in Wistar
thyrocytes, are thus puzzling. There are a number of
possible explanations for the discrepancy between the
in vivo and in vitro data. First, the inclusion of FCS in our
culture system may have exposed the thyrocytes to
uncharacterized growth factors (or growth inhibitors); our
experiments therefore cannot exclude diVerences in
sensitivity for such factors between the two diVerent
strains of rats. Secondly, the [3H]TdR uptake into in vitro
cultured thyrocytes may not reflect true cell proliferation
(Maurer 1981). However, our experiments using aphidi-
colin, X-irradiation and BrdU labelling indicate that our
data represent valid measurement of such proliferation. If
valid, these data underline once more the danger of
extrapolating in vitro data to the in vivo situation. In vivo
goitre development is, indeed, far more complex than
in vitro thyrocyte proliferation. First, goitre development is
influenced by growth factors produced by cells other than
thyrocytes – that is, by stromal cells normally present in the
vicinity of the thyrocytes, such as fibroblasts and endo-
thelial cells (Bechtner et al. 1993). Such cells were virtually
absent from our in vitro follicle culture system. It is known
also that the addition of matrix factors to thyroid follicle
cultures greatly alters the proliferative rate of the thyro-
cytes (Toda et al. 1995). Secondly, goitre development is
not only the outcome of thyrocyte proliferation, but also
influenced by the rate of apoptosis of thyrocytes. There-
fore, further experiments, such as in vivo BrdU labelling
and the use of apoptosis markers, are needed, to shed more
light on the discrepancy we have described here.
Regardless of the need to explore that discrepancy fur-
ther, there is one striking similarity of our in vitro obser-
vations with those made in the OS chicken: a decreased in
vitro growth rate of thyrocytes in the pre-autoimmune stage
(Truden et al. 1983). It has been suggested that this abnor-
mal, intrinsic, low proliferative rate of OS chicken thyro-
cytes reflected an inborn derangement of function (Truden
et al. 1983) – that is, a defect in the handling of iodine
(fewer I atoms were found to be built into the chicken
thyroglobulin; Sundick 1989). Other pre-autoimmune
thyroid abnormalities found in the OS chicken included
TSH-independent hyperfunction, such as a high oxidative
metabolism, a high iodine uptake and an incomplete
suppression of this uptake (Sundick 1989). These signs
of hypermetabolism were suggested to be mechanisms
compensating for the iodine-handling defect.
It is tempting to speculate that the hyperplastic goitre
development and the relatively high follicular T4 output of
our BB-DP rats of 9 weeks and older also represent
compensatory mechanisms for the postulated mild defect
in the handling of iodine. Evidence for such a mild defect
(a low iodine/thyroglobulin ratio, and an abnormal,
incomplete WolV–ChaikoV eVect) has been reported by Li
& Boyages (1994). We have observed that young BB-DP
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rats are extremely sensitive to perchlorate discharge and
respond to low iodine diets with an extremely low plasma
concentration of T4 (Mooij et al. 1992, Mooij 1993).
However, the existence of a mild defect in iodine organi-
fication in BB-DP rats has also been disputed (Rajatanivan
et al. 1983), and clearly more investigations are needed in
the very young BB-DP rat (less than 9 weeks old) to
establish or refute such metabolic abnormality and its
compensations. In patients with Hashimoto’s thyroiditis,
however, organification defects have been well described
(Takeuchi et al. 1970).
Whatever the reasons may be for the small goitre
development in the BB-DP rat, we believe that the
dendritic cells accumulate in such hyperplastic thyroids to
serve a function: the regulation of the abnormal growth
rate and metabolism of the thyrocytes (see Introduction).
What factors and cytokines are attracting these dendritic
cells to the BB-DP rat thyroid? Histologically, we could
not find a diVerence in ICAM-1 expression between
BB-DP and Wistar thyroid endothelial cells in the pre-
thyroiditis phase. However, after the development of focal
thyroiditis in the BB-DP rat, ICAM-1 became clearly
expressed on the endothelial cells in the thyroiditis areas,
suggesting a role of this adhesion molecule late in the
autoimmune process.
MCP-1 was produced in vitro by thyroid follicles, but in
variable quantities, and there was no diVerence between
BB-DP and Wistar thyroid follicles. Low levels of MCP-
1 have also been observed in primary cultures of human
thyrocytes isolated from patients with Graves’ disease.
Only after stimulation with cytokines such as IL-1-Æ,
TNF-Æ and, to a lesser extent, IFN-ª, were significant
amounts of MCP-1 detected (Kasai et al. 1996).
BB-DP thyroid follicles isolated in the hyperplastic
goitre phase did, however, produce more IL-6 than Wistar
thyrocytes. Contaminating leucocytes could not have been
the source of this IL-6, as such contaminating cells were
not present in our culture system. In vitro IL-6 production
by thyrocytes has been reported before. It is stimulated by
TSH (see also this report), IL-1-Æ and epidermal growth
factor (Hirano et al. 1990, Bartalena et al. 1995). IL-6 has a
wide variety of activities: it is involved in the regulation of
the immune response by an enhancement of T cell pro-
liferation, a stimulation of B cells to produce antibodies and
an enhancement of the activity of GM-CSF (Hirano et al.
1990). It also has a role in the transition of monocytes to
dendritic cells (Mooij et al. 1994, Peters et al. 1996), hence
a role of this cytokine in the intrathyroid accumulation of
dendritic cells in BB-DP rats is likely. IL-6 also has a role in
the stimulation of growth of thyrocytes (Nishiyama et al.
1993, Shimomura et al. 1994), and it is thus intriguing that
the BB-DP thyrocytes, although having a low in vitro
proliferative rate, produced more IL-6 (see above).
With regard to TNF-Æ, we were unable to detect,
either in situ or in vitro (culture of isolated follicles),
a noteworthy production of TNF-Æ by thyrocytes at a
stage at which lymphocytes had not yet infiltrated the
thyroid.
With regard to yet other factors that play a part in
accumulation of dendritic cells, namely autoantigens, we
found no noteworthy diVerence between the production
of thyroglobulin in BB-DP and Wistar rat thyroid follicles
kept in culture. This might indicate that the expression of
this autoantigen does not play a major part in the increased
accumulation of the APCs. However, we cannot exclude
the possibility that the degree of iodination of thyro-
globulin is important (Sundick 1989), and that other
autoantigens, such as thyroperoxidase, are expressed at a
higher level in our BB-DP thyrocyte cultures.
In conclusion, our report describes hyperplastic goitre
development in the BB-DP rat at a stage when the thyroid
autoimmune reaction is initiated. At the same time there
was also an increased production of T4 and IL-6 by the
thyrocytes. It is conceivable that these thyroid abnormalities
create a micromilieu that favours the attraction of APCs and
the initiation of the thyroid autoimmune response.
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